HomePHIO • NASDAQ
add
Phio Pharmaceuticals
Nakaraang pagsara
$5.72
Sakop ng araw
$5.22 - $5.73
Sakop ng taon
$4.50 - $29.07
Market cap
30.37M USD
Average na Volume
7.26K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 1.06M | -27.72% |
Net na kita | -2.15M | 40.20% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | -2.21M | 38.43% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 6.48M | -28.33% |
Kabuuang asset | 6.85M | -29.40% |
Kabuuang sagutin | 1.25M | -47.87% |
Kabuuang equity | 5.60M | — |
Natitirang share | 510.19K | — |
Presyo para makapag-book | 0.52 | — |
Return on assets | -68.11% | — |
Return on capital | -82.62% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -2.15M | 40.20% |
Cash mula sa mga operasyon | -2.01M | 25.74% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | -4.00K | 89.47% |
Net change in cash | -2.02M | 26.62% |
Malayang cash flow | -1.21M | 10.25% |
Tungkol
Phio Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
Itinatag
2011
Headquarters
Website
Mga Empleyado
9
